Harmony Biosciences Holdings vs Travere Therapeutics
Harmony Biosciences Holdings vs Travere Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Harmony Biosciences Holdings is on 57/100 and Travere Therapeutics on 51/100.
Where each one leads
Harmony Biosciences Holdings
- our overall score: 57/100 against 51/100
- headcount: 332 against 125
- funding raised: $401M against $63.0M
Travere Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Harmony Biosciences Holdings | Travere Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders. | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2017 | 2015 |
| Headquarters | Plymouth Meeting, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Harmony Biosciences Holdings | Travere Therapeutics |
|---|---|---|
| Employees | 332 | 125 |
| Total funding | $401M | $63.0M |
| Latest round | IPO | Convertible Note |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 22,304 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Harmony Biosciences Holdings | Travere Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 51/100 |
| Traction | 60/100 | 59/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 33/100 | 5/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 55/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Harmony Biosciences Holdings | Travere Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery, Tailwind CSS |
| Analytics | Google Tag Manager | Google Tag Manager, Linkedin Insight |
Harmony Biosciences Holdings vs Travere Therapeutics: common questions
Which is better, Harmony Biosciences Holdings or Travere Therapeutics?
On our 0-100 score Harmony Biosciences Holdings rates higher (57/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Harmony Biosciences Holdings and Travere Therapeutics compare on the numbers?
Harmony Biosciences Holdings leads on our overall score (57/100 against 51/100), headcount (332 against 125), funding raised ($401M against $63.0M).
Read the full Harmony Biosciences Holdings review and pricing or the Travere Therapeutics review and pricing. You can also browse other Harmony Biosciences Holdings alternatives we track.